U.S. Markets open in 1 hr 37 mins

Cymabay Therapeutics (CBAY) Rises: Stock Moves 9.2% Higher

Zacks Equity Research

Cymabay Therapeutics, Inc. CBAY was a big mover last session, as the company saw its shares rise over 9% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.60 to $2.18 in the past one-month time frame.

None of the estimates for this stock were revised in the last 30 days, while the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cymabay Therapeutics carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

CymaBay Therapeutics Inc. Price


CymaBay Therapeutics Inc. Price | CymaBay Therapeutics Inc. Quote

Another similarly-ranked stock in the same industry is Impax Laboratories, Inc. IPXL. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Top 10 Stocks for 2017

In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017? Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Impax Laboratories, Inc. (IPXL): Free Stock Analysis Report
CymaBay Therapeutics Inc. (CBAY): Free Stock Analysis Report
To read this article on Zacks.com click here.